Financiación de la investigación sanitaria y carga de enfermedad por hepatitis B y C

García-Fulgueiras, Ana; García-Pina, Rocío; García-Ortúzar, Visitación.
Rev. esp. salud pública ; 83(4): 587-588, jul.-ago. 2009.
Artículo en Español | IBECS (España) | ID: ibc-74036

Documentos relacionados

  1. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020.
  2. Cost-effective options for the prevention and management of gastrointestinal and liver disease in the Asia-Pacific region.
  3. Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation.
  4. Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income.
  5. Mobilising a global response to hepatitis: Lessons learned from the HIV movement.
  6. The Growing Problem of Hepatitis C Virus Infection: The Case of West Virginia.
  7. Hepatitis B and C seroprevalence among residents in Lagos State, Nigeria: A population-based survey.
  8. Barriers and Strategies for Hepatitis B and C Elimination in Pakistan.
  9. Evidence for the elimination of viral hepatitis B and C in Egypt: Results of a nationwide survey in 2022.
  10. Cost-benefit evaluation of a preventive intervention on the biological risk in health: the accidental puncture during the administration of insulin in the University Hospital "Federico II" of Naples.